Royal Bank Of Canada Has Lowered Expectations for Cigna Group (NYSE:CI) Stock Price

Cigna Group (NYSE:CI) had its price target dropped by investment analysts at Royal Bank Of Canada from $344.00 to $333.00 in a note issued to investors on Friday, MarketBeat.com reports. The brokerage currently has an “outperform” rating on the health services provider’s stock. Royal Bank Of Canada’s price objective points to a potential upside of 13.93% from the stock’s previous close.

CI has been the topic of a number of other research reports. Wells Fargo & Company decreased their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 5th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $307.00 price objective on shares of Cigna Group in a report on Tuesday, January 6th. Guggenheim restated a “buy” rating and set a $318.00 target price on shares of Cigna Group in a report on Monday, February 2nd. Mizuho set a $325.00 price target on Cigna Group in a research report on Friday, January 9th. Finally, The Goldman Sachs Group lowered their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research report on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $323.16.

Cigna Group Stock Performance

Shares of NYSE CI opened at $292.29 on Friday. The stock’s 50-day moving average is $274.77 and its 200 day moving average is $283.83. The stock has a market cap of $78.08 billion, a price-to-earnings ratio of 13.18, a P/E/G ratio of 1.04 and a beta of 0.27. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the prior year, the firm earned $6.64 earnings per share. Cigna Group’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in CI. Vanguard Group Inc. boosted its stake in shares of Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after purchasing an additional 414,834 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Cigna Group by 8.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after buying an additional 903,334 shares during the period. Dodge & Cox boosted its position in Cigna Group by 4.0% during the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after acquiring an additional 354,615 shares in the last quarter. Sanders Capital LLC grew its holdings in shares of Cigna Group by 0.5% during the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after acquiring an additional 35,150 shares during the period. Finally, Norges Bank bought a new position in shares of Cigna Group in the 2nd quarter worth approximately $1,110,426,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 earnings and revenue beat — Cigna reported adjusted EPS of $8.08 and revenue of $72.5B, both above consensus, driven by Evernorth growth and higher specialty volumes; investors are rewarding the beat and evidence of durable revenue momentum. Cigna Q4 Highlights
• Positive Sentiment: FTC settlement over insulin pricing reduces regulatory overhang and includes commitments to change PBM pricing practices — this removes a major legal uncertainty and may support multiple expansion. FTC Settlement Coverage
• Positive Sentiment: Dividend increase — the board raised the quarterly dividend to $1.56 (3.3% increase), a modest buyback/dividend-friendly signal that supports income investors. Dividend Announcement
• Neutral Sentiment: Analyst price target moves are mixed — Leerink raised its PT to $297 but kept a “market perform” rating, while RBC trimmed its PT to $333 but maintained an “outperform” view; these moves show cautious optimism but limited near-term upside consensus. Leerink PT Change RBC PT Change
• Neutral Sentiment: Evernorth and specialty volumes are growth drivers cited on the call — supportive for revenue mix and long-term profit potential, though investors will watch margin dynamics. Evernorth Growth Coverage
• Negative Sentiment: 2026 guidance slightly below some Street expectations — Cigna set FY 2026 EPS guidance at at least $30.25, a touch under consensus and accompanied by commentary about ongoing medical-cost and margin pressure; this tempered the upside from the quarter for some investors. Guidance Miss Coverage

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.